Point Of Care Diagnostics Market to Witness a Strong Growth During 2022 – 2030

The global point of care diagnostics market size was valued at USD 37.03 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2022 to 2030.

The global Point Of Care Diagnostics Market size is expected to reach USD 68.59 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.8% from 2022 to 2030. The introduction of advanced technologies such as Telehealth enabled POCT is expected to fuel market growth. Furthermore, the rise in the geriatric population and their need for accessible home-based care are anticipated to drive the market.

The adoption of POCT in emerging economies such as Africa and Latin America is anticipated to be a growth determinant of the global POCT market. The authorities are decentralizing the healthcare system and increasing their investments. For instance, the African regulations in Kenya allotted USD 346.7 to Managed Equipment Services project for the government's initiative toward modernizing facilities by procuring new equipment. The Ministry of Health selected GE Health and Philips to offer equipment across 47 countries. Similarly, Latin America decentralized IVD testing, which encourages private players to take strategic initiatives to meet the region’s existing demand for affordable POCT, especially in the infectious diseases segment.

Currently developed POC devices and tests are employed across different medical diagnostic applications, including cancer, pregnancy, and infectious diseases. Patients and physicians employ POC tests to screen conditions, confirm diagnoses, and design suitable therapeutic approaches based on patient health. However, the enthusiasm displayed by different consumers, such as doctors, patients, and caregivers, varies widely. This dynamic consumption pattern of POC diagnostic products is also attributed to economic scalability, financial interests, and lack of a universal healthcare structure.

In the light of COVID-19, the lockdown imposed across the globe has necessitated virtual visits and rapid diagnostic tests that assist patients to avoid hospital visits. Post-lockdown, the eHealth strategy is the emerging area of priority and investment such as an automated patient appointment system, lab result transmission system, healthcare workers' communication system, and medical products procurement system for the companies and governments. It is anticipated to continue to prioritize home-based healthcare delivery even after the pandemic, especially for patients with pre-existing conditions. For instance, NeuroMetrix, Inc. appointed a team to develop the business of DPNCheck, a POCT for peripheral neuropathies. The team is responsible for expanding the footprint in the healthcare market and focusing on the Medicare Advantage population. 

Related Press Release@ Point Of Care Diagnostics Market Report

Point Of Care Diagnostics Market Report Highlights

• The glucose testing product segment held the second-largest revenue share in 2021. The high prevalence of diabetes, coupled with the requirement of constant monitoring of blood sugar levels, is contributing to the segment growth
• The home end-use segment is expected to grow lucratively over the forecast period attributed to significant traction of at-home or self-testing for COVID-19. POCT devices are easy to use and do not, mandatorily, require any modern lab infrastructure for testing simpler target analytes in a patient's sample
• North America dominated the global market in 2021 owing to the increasing demand for new technologies, a large pool of key players, and advanced healthcare infrastructure
• The Asia Pacific is expected to grow considerably in the future owing to the rising prevalence of cancer, diabetes, cardiovascular diseases, and infectious diseases. The increasing population with limited disposable income is the potential target market for the key players in the region

Reviews

[Spamalott]

So for fun, I added another review of these crooks. This one on Quora.

For more than a year, this company has regularly invaded the Writers Café website, one of the oldest, non-commercial writing venues on the internet. And they do that in spite of repeated requests to stop. Does an ethical company do that? No.

Ignoring site rules and the desires of the members, they drop spam for their company, falsely listing that spam as a chapter in a pretend book. Does an ethical company lie that way? No. Does a successful company have to resort to such tactics when advertising on the site is available at reasonable cost? Absolutely not.

In fact, the author of the spam is so inept that he can’t handle the HTML formatting that people experienced in presentation on the internet take for granted.

He lacks skill in working with the HTML language used on the Internet, so all the indentations he included were lost—both of sections under a heading, and paragraphing within that section. And he either never noticed, or didn’t take the time to learn how to fix the problem. Either way…

Aside from being dishonest, and inept, posting spam in the area reserved for the stories and poetry of members is a violation of site rules, disrespectful of the members, and, demonstrates that to them, a potential coin in the pocket is more important than ethics.

They’re supposed to be enhancing their reputation and attracting customers with that spam. Instead, they demonstrate a lack of writing skills, because the supposed condensations of the actual report are written in a way that bores the reader in a paragraph or two. That’s dumb because their entire sales pitch is based on how well they write.

In short, while the company expects people to see them as being experts in their field, they cannot handle a page of promotion for what they sell. You can see the inept formatting of today’s spam here:

https://www.writerscafe.org/writing/Industryinsights/2829563/

[Spamalott]

Ahh, the lowest of the low Indian data w****s is spamming for their poorly written crap on a site where no one ever buys one. So add stupid to poor writing.